prikaz prve stranice dokumenta Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu
  Download
PDF 1000.2 KB
master's thesis
Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu
diplomski rad
2016. urn:nbn:hr:167:288043
Rušić, Doris
University of Split
Faculty of Chemistry and Technology
Division of Chemistry
University of Split
School of Medicine

Cite this document

Rušić, D. (2016). Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad (Master's thesis). Split: University of Split, Faculty of Chemistry and Technology; Split: University of Split, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:167:288043

Rušić, Doris. "Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad." Master's thesis, University of Split, Faculty of Chemistry and Technology; University of Split, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:167:288043

Rušić, Doris. "Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad." Master's thesis, University of Split, Faculty of Chemistry and Technology; University of Split, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:167:288043

Rušić, D. (2016). 'Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad', Master's thesis, University of Split, Faculty of Chemistry and Technology; University of Split, School of Medicine, accessed 19 April 2024, https://urn.nsk.hr/urn:nbn:hr:167:288043

Rušić D. Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad [Master's thesis]. Split: University of Split, Faculty of Chemistry and Technology; Split: University of Split, School of Medicine; 2016 [cited 2024 April 19] Available at: https://urn.nsk.hr/urn:nbn:hr:167:288043

D. Rušić, "Bezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad", Master's thesis, University of Split, Faculty of Chemistry and Technology, Split; University of Split, School of Medicine, Split, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:167:288043

Please login to the repository to save this object to your list.
Metadata
TitleBezreceptni lijekovi izvan ljekarničke mreže u RH s osvrtom na acetilsalicilatnu kiselinu : diplomski rad
Title (english)Over-the-counter medicinal products in drug outlets and general sales with reference to acetylsalicylic acid : master thesis
AuthorDoris Rušić
MentorSiniša Tomić (mentor)
Committee memberDarko Modun (predsjednik povjerenstva)
Committee memberZoran Valić (član povjerenstva)
Committee memberSiniša Tomić (član povjerenstva)
GranterUniversity of Split
Faculty of Chemistry and Technology
(Division of Chemistry)
Split
GranterUniversity of Split
School of Medicine
Split
Defense date and country2016-10-21, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Pharmacy
Abstract
Cilj istraživanja: Cilj ovog istraživanja je ispitati opravdanost reklasifikacije bezreceptnih lijekova koji sadrže djelatnu tvar acetilsalicilatnu kiselinu registriranih u RH u lijekove s odobrenjem za izdavanje u ljekarni i specijaliziranim prodavaonicama. Materijal i metode: Sastavljen je usporedni pregled regulacijskog statusa OTC lijekova koji sadrže djelatnu tvar ASK registriranih u izabranim zemljama članicama EU. Pregledana je legislativa koja regulira promet i distribuciju OTC lijekova u RH te je napravljena usporedba prijavljenih sumnji na nuspojave lijekova koji sadrže djelatnu tvar ASK i lijekova koji sadrže djelatnu tvar paracetamol ili ibuprofen zaprimljenih u RH u 2015. godini. Rezultati: Lijekovi s odobrenjem za izdavanje u specijaliziranim prodavaonicama imaju dopuštenje za oglašavanje prema stanovništvu, OTC lijekovi koji sadrže djelatnu tvar ASK također imaju dopuštenje za oglašavanje prema stanovništvu. Usporedbom prijava sumnji na nuspojave lijekova koji sadrže djelatnu tvar ASK, ibuprofen ili paracetamol utvrđeno je da nije bilo značajne razlike u ozbiljnosti prijava sumnji na nuspojave lijekova. Također nije pronađena statistički značajna razlika u ishodu nuspojava za spomenute lijekove. Zaključci: Nisu pronađene razlike u prijavljenim sumnjama na nuspojave lijekova koji sadrže djelatnu tvar ASK i lijekova koji sadrže djelatnu tvar ibuprofen ili paracetamol, stoga nema ograničenja za promjenu mjesta izdavanja bezreceptnih lijekova u RH koji sadrže djelatnu tvar ASK. Potrebno je definirati zakonski okvir za spomenutu reklasifikaciju bezreceptnih lijekova.
Abstract (english)
Objectives: The aim of this study was to examine the justification for the deregulation of Over-the- Counter (OTC) medicinal products containing active substance acetylsalicylic acid (ASA), registered in the Republic of Croatia, from Pharmacy Only to Pharmacy and Drug Outlet Medicinal Products. Material and Methods: A comparative review was made of the regulatory status of OTC medicinal products containing active substance ASA in a selected number of EU member states. We analysed the legislation on distribution of OTC medicinal products in the Republic of Croatia and compared reported adverse reactions of medicinal products with active substances ASA, ibuprofen or paracetamol reported in the Republic of Croatia in the year 2015. Results: Medicinal products classified as Pharmacy and Drug Outlet Medicinal Products have permission to advertise to the general public. OTC medicinal products containing the active substance ASA also have permission to advertise to the general public. Analysis of adverse events reported with medicinal products containing active substances ASA, ibuprofen or paracetamol found that there were no significant differences in the number of reported adverse reactions classified as serious. There was no statistically significant difference in the outcome of the adverse reactions among these medicinal products. Conclusions: There was no difference in reported adverse reactions among medicinal products containing active substance ASA, ibuprofen or paracetamol, therefore there is no obstacle for the deregulation of OTC medicinal products containing active substance ASA, registered in the Republic of Croatia, from Pharmacy Only to Pharmacy and Drug Outlet Medicinal Products. A reagulatory framework should be developed to address this deregulation.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:167:288043
Study programmeTitle: Pharmacy
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: magistar/magistra farmacije (magistar/magistra farmacije)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2016-11-22 10:31:38